Taroh Satoh

机构：Osaka City University, Osaka University Hospital, The University of Osaka · ORCID：0000-0002-4615-2638

发表论文 515 篇 · 总被引 26042 次 · h-index 56

代表论文

• Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations (2025 · Clinical Cancer Research · 被引 7)
• Targeting fibroblast activation protein in solid tumors via LNP-mediated CAR-mRNA delivery promotes durable regression in murine models (2025 · Scientific Reports · 被引 6)
• Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations (2025 · Annals of Surgical Oncology · 被引 4)
• ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer (2025 · Future Oncology · 被引 3)
• Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trial (2025 · Gastric Cancer · 被引 1)
• Preliminary results of a first-in-human phase 1b (aCCeleR8-001) study of S-531011, a humanized anti-CCR8 monoclonal antibody, in patients with advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 1)